Results
|
701.
|
|
|
702.
|
Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor. [electronic resource] by
- Hofmann, W K
- Ganser, A
- Seipelt, G
- Ottmann, O G
- Zander, C
- Geissler, G
- Hoffmann, K
- Höffken, K
- Fischer, J T
- Isele, G
- Hoelzer, D
Producer: 19990429
In:
Annals of hematology vol. 78
Availability: No items available.
|
|
703.
|
|
|
704.
|
Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification. [electronic resource] by
- Font, P
- Loscertales, J
- Benavente, C
- Bermejo, A
- Callejas, M
- Garcia-Alonso, L
- Garcia-Marcilla, A
- Gil, S
- Lopez-Rubio, M
- Martin, E
- Muñoz, C
- Ricard, P
- Soto, C
- Balsalobre, P
- Villegas, A
Producer: 20130314
In:
Annals of hematology vol. 92
Availability: No items available.
|
|
705.
|
|
|
706.
|
|
|
707.
|
|
|
708.
|
|
|
709.
|
|
|
710.
|
|
|
711.
|
|
|
712.
|
|
|
713.
|
|
|
714.
|
|
|
715.
|
|
|
716.
|
|
|
717.
|
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation. [electronic resource] by
- Saito, K
- Nakamura, Y
- Aoyagi, M
- Waga, K
- Yamamoto, K
- Aoyagi, A
- Inoue, F
- Nakamura, Y
- Arai, Y
- Tadokoro, J
- Handa, T
- Tsurumi, S
- Arai, H
- Kawagoe, Y
- Gunnji, H
- Kitsukawa, Y
- Takahashi, W
- Furusawa, S
Producer: 20000726
In:
International journal of hematology vol. 71
Availability: No items available.
|
|
718.
|
|
|
719.
|
|
|
720.
|
|